These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22210675)

  • 1. B cell strategy to maintain remission in ANCA-associated vasculitides?
    Adler S; Villiger PM
    J Rheumatol; 2012 Jan; 39(1):4-5. PubMed ID: 22210675
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.
    Roubaud-Baudron C; Pagnoux C; Méaux-Ruault N; Grasland A; Zoulim A; LE Guen J; Prud'homme A; Bienvenu B; de Menthon M; Camps S; LE Guern V; Aouba A; Cohen P; Mouthon L; Guillevin L;
    J Rheumatol; 2012 Jan; 39(1):125-30. PubMed ID: 22089465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.
    Santana AN; Woronik V; Halpern AS; Barbas CS
    J Bras Pneumol; 2011; 37(6):809-16. PubMed ID: 22241040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.
    Singer O; McCune WJ
    Curr Opin Rheumatol; 2017 May; 29(3):248-253. PubMed ID: 28306595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
    Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Ding L; Iklé D; Villareal M; Lim N; Brunetta P; Fervenza FC; Monach PA; Stone JH;
    Arthritis Rheumatol; 2015 Jun; 67(6):1629-36. PubMed ID: 25776953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic interventions for systemic vasculitis.
    Hoffman GS
    JAMA; 2010 Dec; 304(21):2413-4. PubMed ID: 21060105
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti B-cell-antibody treatment for maintenance of remission in granulomatosis with polyangiitis and microscopic polyangiitis].
    de Groot K; Aries PM; Haubitz M; Hellmich B; Lamprecht P; Thiel J
    Dtsch Med Wochenschr; 2020 Jan; 145(1):40-46. PubMed ID: 31914468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating elderly patients with ANCA-associated vasculitis.
    Jefferson JA
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1110-3. PubMed ID: 26100458
    [No Abstract]   [Full Text] [Related]  

  • 11. [B-cell targeted therapy in patients with granulomatosis with polyangiitis and microscopic polyangiitis].
    Moosig F; Aries PM; de Groot K; Haubitz M; Hellmich B; Iking-Konert C; Wagner AD; Zänker M
    Dtsch Med Wochenschr; 2014 Oct; 139(44):2248-53. PubMed ID: 25334077
    [No Abstract]   [Full Text] [Related]  

  • 12. Remission maintenance in ANCA-associated vasculitis: does one size fit all?
    Berti A; Specks U
    Expert Rev Clin Immunol; 2019 Dec; 15(12):1273-1286. PubMed ID: 31762340
    [No Abstract]   [Full Text] [Related]  

  • 13. S3. Rituximab for ANCA-associated vasculitides: the French experience.
    Charles P; Guillevin L
    Presse Med; 2013 Apr; 42(4 Pt 2):534-6. PubMed ID: 23453207
    [No Abstract]   [Full Text] [Related]  

  • 14. [THE MECHANISMS OF ACTION OF RITUXIMAB].
    Gil'deeva GN; Kudlai DA; Luk'yanov SV
    Eksp Klin Farmakol; 2015; 78(12):51-6. PubMed ID: 27051930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.
    Hiemstra TF; Walsh M; Mahr A; Savage CO; de Groot K; Harper L; Hauser T; Neumann I; Tesar V; Wissing KM; Pagnoux C; Schmitt W; Jayne DR;
    JAMA; 2010 Dec; 304(21):2381-8. PubMed ID: 21060104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis.
    Langford CA
    Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):31-4. PubMed ID: 21447129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients.
    Charles P; Néel A; Tieulié N; Hot A; Pugnet G; Decaux O; Marie I; Khellaf M; Kahn JE; Karras A; Ziza JM; Deligny C; Tchérakian C; Guillevin L;
    Rheumatology (Oxford); 2014 Mar; 53(3):532-9. PubMed ID: 24282319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of gynaecological involvement of granulomatosis with polyangiitis (Wegener's granulomatosis) by rituximab.
    Bastone P; Squifflet JL; Marbaix E; Houssiau F
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-142-4. PubMed ID: 26016766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S1. Rituximab for ANCA-associated vasculitis: the experience in the United States.
    Clain JM; Specks U
    Presse Med; 2013 Apr; 42(4 Pt 2):530-2. PubMed ID: 23477713
    [No Abstract]   [Full Text] [Related]  

  • 20. [Update on treatment of ANCA-associated vasculitis: Granulomatosis with polyangiitis and Microscopic Polyangiitis].
    Holle JU; Hellmich B; Moosig F
    Z Rheumatol; 2022 May; 81(4):280-285. PubMed ID: 35061059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.